DANIEL S WOLOSHEN Insider Trading $GTCB rEVO Biologics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL S WOLOSHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL S WOLOSHEN. DANIEL S WOLOSHEN is Senior VP and General Counsel in rEVO Biologics, Inc. ($GTCB) and SVP and General Counsel in rEVO Biologics, Inc. ($GTCB).
DANIEL S WOLOSHEN in rEVO Biologics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL S WOLOSHEN: Senior VP and General Counsel, SVP and General Counsel
Holdings: 22,033 shares
Latest Transaction: Nov 04 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL S WOLOSHEN in rEVO Biologics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 1.21 | 11,717 | 14,178 | 22,033 | 10.3 K to 22 K (+113.58 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 10,316 | 11.5 K to 10.3 K (-10.15 %) |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.37 | 35,000 | 12,950 | 35,000 | |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 5,400 | 0 | 114,825 | 109.4 K to 114.8 K (+4.93 %) |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 30,600 | 0 | 109,425 | 78.8 K to 109.4 K (+38.82 %) |
| Mar 12 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Sell | S | 0.57 | 17,000 | 9,699 | 78,825 | 95.8 K to 78.8 K (-17.74 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 30,491 | 0 | 95,825 | 65.3 K to 95.8 K (+46.67 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Buy | P | 0.89 | 1,200 | 1,068 | 65,334 | 64.1 K to 65.3 K (+1.87 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 1.04 | 35,000 | 36,400 | 35,000 | |
| Dec 22 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Sell | S | 1.10 | 7,500 | 8,221 | 64,134 | 71.6 K to 64.1 K (-10.47 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 1.23 | 1,000 | 1,230 | 71,634 | 70.6 K to 71.6 K (+1.42 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 1.03 | 25,000 | 25,750 | 25,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 34,715 | 0 | 70,634 | 35.9 K to 70.6 K (+96.65 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 1.71 | 27,000 | 46,170 | 27,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Grant | A | 0.00 | 5,222 | 0 | 35,919 | 30.7 K to 35.9 K (+17.01 %) |
| Jan 10 2005 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 1.44 | 274 | 395 | 30,697 | 30.4 K to 30.7 K (+0.90 %) |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Oct 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 1.31 | 404 | 529 | 30,423 | 30 K to 30.4 K (+1.35 %) |
| Jul 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 1.70 | 1,243 | 2,113 | 30,019 | 28.8 K to 30 K (+4.32 %) |
| Apr 12 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 2.20 | 841 | 1,851 | 28,776 | 27.9 K to 28.8 K (+3.01 %) |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 3.96 | 25,000 | 99,000 | 25,000 |
Page: 1